Good Distribution Practices (GDP) adopted by PIC/S

Recommendation
9 September 2025
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
Good Distribution Practice has now found its way into the Pharmaceutical Inspection Co-Operation Scheme (PIC/S).
Globalisation with longer and more complex supply chains but also counterfeiting problems have been forcing pharmaceutical industry and inspectorates to challenge their current practices. As a consequence, PIC/S - fostering the cooperation established between the participating authorities in the field of inspection and related areas - has now amended its Pharmaceutical Inspection Co-operation Scheme Document defining both Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) as core areas. In the document it is now referred to Good Manufacturing and Distribution Practice (GMDP). Changing over from GDP to GMDP does mean that PIC/S will now also include GDP aspects in its co-operation, harmonisation and training activities.
Source: Pharmaceutical Inspection Co-operation Scheme
Wolfgang Schmitt
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)
Related GMP News
15.07.2025New Swissmedic Technical Interpretation on Returns of Medicinal Products
15.07.2025Two new GDP Non-Compliance Reports from Austria and Ireland published in the EudraGMDP database
15.07.2025Reminder: Participate in the GDP Implementation Survey until 31 July 2025
15.07.2025PDA Publishes Results of Transportation Validation Benchmarking Survey
10.06.2025Stimuli Article Proposes Revision of USP Definition of Controlled Room Temperature (CRT)
10.06.2025New MHRA Blog Post: Supplying Medicines to Ships, Aircraft and Oil Platforms